Literature DB >> 23636192

Incidence of knee sepsis after ACL reconstruction at one institution: the impact of a clinical pathway.

V Franklin Sechriest1, Joseph R Carney, Michael A Kuskowski, James L Haffner, Mollie J Mullen, Dana C Covey.   

Abstract

BACKGROUND: After experiencing an unusually high incidence of knee sepsis after anterior cruciate ligament (ACL) reconstruction, we sought to (1) describe how we resolved this problem through temporary discontinuation of the procedure, formation of a multidisciplinary ACL Task Force, systematic investigation of clinical data and institutional care practices, and development and implementation of an evidence-based ACL Clinical Pathway (the Pathway); and (2) report our findings and results.
METHODS: From 1999 through 2008, thirty-seven cases of knee sepsis after ACL reconstruction were recorded at our institution. In 2008 (yearly incidence, 4.4%), ACL reconstructions were temporarily suspended and a Task Force was assembled to (1) identify infection risk factors or epidemiological links among cases, (2) inspect environment and processes for possible infection sources, and (3) update existing perioperative practices according to current evidence-based guidelines to reduce surgical site infection risk. These actions led to the development of the Pathway for patients and providers. The rates of knee sepsis before and after the Pathway was implemented were compared.
RESULTS: There was no consistent risk factor or epidemiologic link among the cases of knee sepsis other than the time and place of the ACL reconstruction. Process review identified shortfalls in decontamination and sterilization of some surgical equipment. Perioperative care practices review revealed wide interprovider variation. Pathway implementation reduced the rate of knee sepsis after ACL reconstruction from 1.96% (twenty-four cases after 1226 ACL reconstructions performed from 2002 to 2008) to 0% (zero cases after 500 ACL reconstructions performed from 2008 to 2011); the difference was significant (p = 0.003).
CONCLUSIONS: When a Task Force investigation suggested that knee sepsis after ACL reconstruction was a multifactorial problem, we implemented and standardized evidence-based perioperative care practices via the institution-wide Pathway, which significantly improved the quality and consistency of care for patients undergoing ACL reconstruction, as well evidenced by the elimination of knee sepsis.

Entities:  

Mesh:

Year:  2013        PMID: 23636192     DOI: 10.2106/JBJS.L.00408

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  5 in total

1.  Functional outcome of septic arthritis after anterior cruciate ligament surgery.

Authors:  Justus Gille; Ulf Gerlach; Ralf Oheim; Thorben Hintze; Bastian Himpe; Arndt-Peter Schultz
Journal:  Int Orthop       Date:  2014-11-25       Impact factor: 3.075

Review 2.  Managing septic arthritis after knee ligament reconstruction.

Authors:  Raúl Torres-Claramunt; Pablo Gelber; Xavier Pelfort; Pedro Hinarejos; Joan Leal-Blanquet; Daniel Pérez-Prieto; Joan C Monllau
Journal:  Int Orthop       Date:  2015-08-04       Impact factor: 3.075

3.  Can additional information be obtained from claims data to support surgical site infection diagnosis codes?

Authors:  David K Warren; Katelin B Nickel; Anna E Wallace; Daniel Mines; Victoria J Fraser; Margaret A Olsen
Journal:  Infect Control Hosp Epidemiol       Date:  2014-10       Impact factor: 3.254

4.  Risk Factors for Septic Arthritis After Anterior Cruciate Ligament Reconstruction: A Nationwide Analysis of 26,014 ACL Reconstructions.

Authors:  Jesper Kraus Schmitz; Viktor Lindgren; Gunnar Edman; Per-Mats Janarv; Magnus Forssblad; Anders Stålman
Journal:  Am J Sports Med       Date:  2021-03-25       Impact factor: 6.202

5.  Gentamicin pre-soaking of hamstring autografts decreases infection rates in anterior cruciate ligament reconstruction.

Authors:  Peter Moriarty; Babar Kayani; Charles Wallace; Justin Chang; Ricci Plastow; Fares S Haddad
Journal:  Bone Jt Open       Date:  2021-01-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.